Advanced Search

Pediatric Infectious Diseases Evaluations

To view Evaluated Articles, you must have an active subscription (or trial) and be signed in.
If you have an active subscription (or trial), please sign in. If your access has expired, you can subscribe at $9.95 per month. If you think you should be able to access this content, please contact us.

Sign in | Free Trial | Subscribe | Recommend to Library

New to F1000? See the Top Rated article below for a free preview of one of our Evaluated Articles.

SECTION HEADS

  • Photo of Adam J Ratner

    Adam J Ratner

    Department of Pediatrics/Infectious Diseases, Columbia University, New York, NY, USA

  • Photo of Lawrence R Stanberry

    Lawrence R Stanberry

    Department of Pediatrics, Columbia University, New York, NY, USA

Section Topics

  • » Anti-infectives & vaccines
  • » Bloodstream/cardiac infections
  • » Bone/joint infections
  • » Central nervous system infections
  • » Congenital & perinatal infections
  • » Gastrointestinal infections
  • » Genitourinary infections
  • » Immunodeficiencies (including HIV), opportunistic infections & fever syndromes
  • » Infection control/healthcare-associated infections
  • » Respiratory tract infections
  • » Sexually transmitted infections
  • » Skin & soft tissue infections
  • » Travel-related infections/neglected tropical diseases/parasitic infections

LATEST EVALUATION

This very important cohort analysis has prospectively followed-up children exposed to zidovudine (ZDV) both in-utero and post-natally as a prevention of mother-to-child HIV transmission. A total of 727 infants enrolled into the Pediatric...

Simon Portsmouth, Pfizer Pharmaceuticals, USA. F1000 Infectious Diseases

8 Must Read

TOP RATED ARTICLE THIS WEEK [FREE TO VIEW]

8
Lack of tumors in infants with perinatal HIV-1 exposure and fetal/neonatal exposure to zidovudine.

Hanson IC, Antonelli TA, Sperling RS, Oleske JM, ..., Lee SS, McSherry G, Mofenson L, Shapiro DE. J Acquir Immune Defic Syndr Hum Retrovirol. 1999 Apr 15; 20(5):463-7

1 Evaluation, most recent by

Simon Portsmouth, Pfizer Pharmaceuticals, USA. F1000 Infectious Diseases

  • Good for Teaching

INDIVIDUALS

Get instant access to evaluations from over 10,000 experts in biology and medicine by taking a free trial or an individual subscription.

Get a FREE Trial Subscribe for $9.95 per month

Already have a subscription? Sign in for instant access. If you are signed in but are not able to view content, your access has expired. Please take out a subscription or recommend F1000 to your librarian.

RECOMMENDATIONS

Send a recommendation to your institution's librarian or information manager to request an extended free trial for all users.

Recommend to your Librarian

LIBRARIANS & INFORMATION MANAGERS

Get an extended free trial supporting clinicians and researchers at your academic or corporate institution.

Request an Institutional Trial

FREE ACCESS

Your institution might be eligible for free access via our sponsorship scheme. Check our sponsorship page.

Faculty of 1000